ABH Healthcare Shares Make Muted Debut, List at ₹99 on NSE

ABH Healthcare shares made a weak stock market debut on Tuesday, 1 September 2026. The stock listed at ₹99 per share on the NSE, representing a discount of 2.94% to its IPO issue price of ₹102.

The listing followed an IPO that was subscribed 1.44 times overall. Qualified institutional buyers (QIBs) led participation with 8.37 times subscription, while the retail portion was subscribed 1.69 times. The non-institutional investor (NII) category received a relatively muted response at 0.29 times.

ABH Healthcare IPO Listing Details

ABH Healthcare launched its IPO as a ₹34.98 crore fresh issue. The IPO had a price band of ₹96 to ₹102 per equity share, with a face value of ₹10 each. The issue opened for subscription on 24 August and closed on 27 August 2026.

The allotment was finalised on 28 August, while refunds were scheduled for 31 August. ABH Healthcare shares were listed on the NSE on 1 September 2026.

The public issue was subscribed 1.44 times overall, with QIBs recording the highest subscription among investor categories.

• Issue Price: ₹102 per share
• NSE Listing Price: ₹99 per share
• NSE Listing Discount: 2.94%
• Overall Subscription: 1.44 times
• Retail Investors: 1.69 times
• Qualified Institutional Buyers (QIB): 8.37 times
• Non-Institutional Investors (NII): 0.29 times

First-Day Trading Performance

Listing Price: ABH Healthcare share price debuted at ₹99 per share on the NSE against its IPO issue price of ₹102, translating into a listing discount of 2.94%.

The discounted debut came after the public issue received an overall subscription of 1.44 times. Investor participation varied considerably across categories.

The QIB portion received the strongest response and was subscribed 8.37 times, while retail investors subscribed 1.69 times their allocated portion. The NII category was subscribed 0.29 times.

Growth Drivers and Challenges

Growth Drivers

Multi-Speciality Healthcare Services: ABH Healthcare provides treatment across 25 medical specialties.

Diversified Medical Offerings: Services span cardiac sciences, neurology, gastroenterology, urology and nephrology.

Government Healthcare Schemes: The hospital provides services under several government-backed healthcare programmes.

Wide Specialty Coverage: Its portfolio includes surgical, diagnostic and specialised healthcare services.

Institutional Healthcare Associations: Services are offered through organisations including ECHS, Railways and BSNL.

Challenges

Competitive Healthcare Industry: The company operates in a highly competitive hospital and healthcare market.

Capital-Intensive Operations: Hospital operations require continued investment in infrastructure, equipment and technology.

Regulatory Requirements: Healthcare services remain subject to multiple regulatory and compliance requirements.

Working Capital Requirements: The company requires funding to support ongoing operational and working capital needs.

Execution of Growth Plans: Future expansion depends partly on effectively deploying IPO proceeds and identifying opportunities.

Utilisation of IPO Proceeds

ABH Healthcare plans to utilise the net proceeds from the fresh issue primarily towards:

• Repayment or prepayment of certain borrowings
• Funding the company's working capital requirements
• Funding inorganic growth through unidentified acquisitions
• General corporate purposes

The IPO was entirely a fresh issue aggregating to ₹34.98 crore, with shares offered within a price band of ₹96 to ₹102 per equity share.

Business and IPO Overview

ABH Healthcare operates under the “Anil Baghi Hospital” brand and is a healthcare service provider offering multi-speciality hospital services.

The company provides services across 25 medical specialties, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT and maxillofacial surgeries.

ABH Healthcare also provides healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY).

The company entered the public markets through a ₹34.98 crore fresh issue offered at a price band of ₹96 to ₹102 per equity share.

The IPO was subscribed 1.44 times overall. The QIB category was subscribed 8.37 times, while retail investors subscribed 1.69 times their allocated portion. The NII category received 0.29 times subscription.

ABH Healthcare made its stock market debut on 1 September 2026, listing at ₹99 per share on the NSE, representing a discount of 2.94% to its IPO issue price of ₹102.